One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Access
PDF Availablehttps://doi.org/10.1136/annrheumdis-2016-209668
Copy DOI
Export
Save
Share
Cite Journal: Annals of the Rheumatic Diseases |  Publication Date: Sep 26, 2016 |
 Citations: 119 |  License type: open-access |
Affiliation: Cedars-Sinai Medical Center, Medical University of Vienna, Pfizer (United States), Johns Hopkins Medicine, Johns Hopkins University, Moldova State University, Hospital Privado, Pharmaceutical Product Development (United States), Stanford University, Oklahoma Medical Research Foundation, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno
ObjectivesThis phase II trial evaluated the efficacy and safety of an interleukin (IL) 6 monoclonal antibody for systemic lupus erythematosus (SLE).MethodsPatients with active disease were randomised to placebo or PF-04236921...
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
